Open AccessP1109: TRIAL IN PROGRESS: PHASE 1B/2 TRIAL OF TAZEMETOSTAT IN COMBINATION WITH VARIOUS TREATMENTS IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Author(s) -
Bessudo A.,
Greenwald D.,
Kazemi M. H.,
Mahindra A.,
Shunyakov L.,
Sondhi M.,
O'Connor H.,
Chen Y.,
Yang J.,
Salles G.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847304.04017.68
Subject(s) - medicine , lenalidomide , multiple myeloma , pomalidomide , oncology , follicular lymphoma , phases of clinical research , neutropenia , mantle cell lymphoma , clinical trial , lymphoma , pharmacology , chemotherapy